XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In-Capital
Adjustment
Additional Paid-In-Capital
Dividends in Excess of Earnings
Adjustment
Dividends in Excess of Earnings
Adjustment
Total
Balances at beginning of period at Dec. 31, 2021 $ 14,009 $ 26 $ (1,340) $ 1,672,882 $ 728 $ (75,218) $ (612) $ 1,611,699
Balances at beginning of period (in shares) at Dec. 31, 2021 600,000 25,612,541            
Net Income (Loss)           154,386   154,386
Issuance of unvested restricted stock, net of forfeitures       (2,441)       (2,441)
Issuance of unvested restricted stock, net of forfeitures (in shares)   14,310            
Exchange of Exchangeable Senior Notes       26,682       26,682
Exchange of Exchangeable Senior Notes (in shares)   413,166            
Net proceeds from sale of common stock   $ 2   351,958       351,960
Net proceeds from sale of common stock (in shares)   1,932,813            
Preferred stock dividend           (1,352)   (1,352)
Common stock dividend           (195,936)   (195,936)
Stock-based compensation       17,507       17,507
Balances at end of period at Dec. 31, 2022 $ 14,009 $ 28   2,065,248   (117,392)   1,961,893
Balances at end of period (in shares) at Dec. 31, 2022 600,000 27,972,830            
Net Income (Loss)           165,588   165,588
Issuance of unvested restricted stock, net of forfeitures       (568)       (568)
Issuance of unvested restricted stock, net of forfeitures (in shares)   34,800            
Exchange of Exchangeable Senior Notes       1,964       1,964
Exchange of Exchangeable Senior Notes (in shares)   32,200            
Net proceeds from sale of common stock       9,564       9,564
Net proceeds from sale of common stock (in shares)   101,061            
Preferred stock dividend           (1,352)   (1,352)
Common stock dividend           (203,698)   (203,698)
Stock-based compensation       19,581       19,581
Balances at end of period at Dec. 31, 2023 $ 14,009 $ 28   2,095,789   (156,854)   1,952,972
Balances at end of period (in shares) at Dec. 31, 2023 600,000 28,140,891            
Net Income (Loss)           161,661   161,661
Issuance of unvested restricted stock, net of forfeitures       (750)       (750)
Issuance of unvested restricted stock, net of forfeitures (in shares)   39,310            
Exchange of Exchangeable Senior Notes (in shares)   28,408            
Net proceeds from sale of common stock       11,757       11,757
Net proceeds from sale of common stock (in shares)   123,224            
Preferred stock dividend           (1,804)   (1,804)
Common stock dividend           (214,716)   (214,716)
Stock-based compensation       17,317       17,317
Net proceeds from sale of preferred stock $ 9,623             9,623
Net proceeds from sale of preferred stock (in shares) 402,673              
Balances at end of period at Dec. 31, 2024 $ 23,632 $ 28   $ 2,124,113   $ (211,713)   $ 1,936,060
Balances at end of period (in shares) at Dec. 31, 2024 1,002,673 28,331,833